-
Researchers evaluate lung cancer treatment that can be inhaled
24 Apr 2024 12:15 GMT
April 24, 2024
5 min read
Researchers at Columbia University's Herbert Irving Comprehensive Cancer Center are investigating a lung cancer treatment that can be delivered directly to the lungs.
The treatment, which involves the inhalation of interleukin …
-
Adjuvant Alectinib Could Aid Disease-Free Survival in ALK-Positive NSCLC
25 Apr 2024 17:08 GMT
… of ALK-Positive Lung Cancer. National Cancer Institute. News release. December 6, 2017 … ;2017/alectinib-fda-untreated-lung-cancer.
3. FDA Approves Alectinib to … -in-patients-with-alk-positive-lung-cancer.
-
NIH Develops AI Tool to Predict Cancer Drug Response from Single Cells
25 Apr 2024 12:07 GMT
In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses data from individual cells inside tumors to predict whether a person's cancer will respond to a specific …
-
Optimizing Oncological Care: The Influence of AI on Insurance Approvals
24 Apr 2024 17:08 GMT
About the Authors
Brian Cox, MBA, MSSF, FACHE, is the director of hospital operations and IT/CIT at Baptist Health System in New Albany, Indiana.
Alberto Coustasse, DrPH, MD, MBA, MPH, is a professor in the Health Informatics Program in the Management …
-
Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
24 Apr 2024 12:14 GMT
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning (“ML”) platform with multiple clinical-stage drug programs, announced …
-
Tecentriq, Cabometyx May Not Improve Survival Over Chemo in NSCLC
23 Apr 2024 22:04 GMT
Patients with non-small cell lung cancer (NSCLC) who do not respond to immunotherapy or whose disease progressed after treatment via immunotherapy face an unmet need, as one expert explained.
“Unless we have special pill therapies for subtypes of lung …
-
Acupuncture in Multiple Myeloma Peripheral Neuropathy: A Systematic Review
24 Apr 2024 12:42 GMT
Introduction
Multiple myeloma (MM) is a neoplastic disorder characterized by the proliferation of plasma cells within the bone marrow.1 Peripheral neuropathy (PN) is a common complication of MM that mainly manifests as sensory neuropathies and motor …
-
How to Lower Your Prostate Cancer Risk
23 Apr 2024 13:39 GMT
ABOUT 300,000 NEW CASES of prostate cancer will be diagnosed this year, according to the American Cancer Society. It’s the second-most common cause of cancer deaths among men. So it’s crucial to know your risk.
Age is the biggest risk factor for prostate …
-
Dublin to host major international cancer forum this week
23 Apr 2024 08:03 GMT
Inaugural Euro-American Forum on Cancer to take place in Farmleigh House
Promoting greater cooperation between the US and Europe in tackling cancer will be the focus of a major international conference taking place in Dublin this week.
Leading figures in …
-
Blood tests hold hope of early cancer detection
22 Apr 2024 09:32 GMT
When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but her husband urged her to take the test anyway.
To her …